FASN and breast cancer: In addition, miR‐195 can directly target acetyl‐CoA carboxylase alpha (ACACA), FASN, HMGCR, and CYP family 27 subfamily B member 1 (CYP27B1) resulting in modulation of de novo GA/cholesterol synthesis and the inhibition of proliferation and invasion of breast cancer cells.162